BioCrossroads Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 3

Professionals

  • Investments
  • 77

  • Portfolio
  • 17

  • Exits
  • 36

Exits

BioCrossroads General Information

Company Description

Founded in 2002, BioCrossroads is a venture capital firm based in Indianapolis, Indiana. The firm prefers to invest in the biotechnology, pharmaceutical, medical device, diagnostic, ag-tech, biotech, and health information technology sectors.

Business Details

Year Founded
2002
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Corporate Office
  • 1210 Waterway Boulevard
  • Suite 5000
  • Indianapolis, IN 46202
  • United States

BioCrossroads Investments (77)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Antigenix Therapeutics 18-Nov-2025 Seed Round Drug Discovery Pre-Clinical Trials
Gate Neurosciences 05-Oct-2022 Other Pharmaceuticals and Biotechnology Generating Revenue
Sabanto 01-Jul-2022 Machinery (B2B) Generating Revenue
MBX Biosciences 01-Jan-2022 Drug Discovery Generating Revenue
Novosteo 29-Dec-2021 Pharmaceuticals Pre-Clinical Trials
Lumavate 01-Dec-2021 Software Development Applications Out of Business
Scioto Biosciences 12-Nov-2021 Drug Delivery Clinical Trials - Phase 2
Kovina Therapeutics 29-Jun-2021 Drug Discovery Pre-Clinical Trials
Gate Neurosciences 29-Mar-2021 Seed Round Other Pharmaceuticals and Biotechnology Generating Revenue
Scioto Biosciences 10-Aug-2020 Early Stage VC Drug Delivery Clinical Trials - Phase 2
You’re viewing 10 of 77 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioCrossroads Exits (36)

Company Name Exit Date Exit Type Exit Size
Zorion Medical 28-Oct-2026 Out of Business
SpeechVive 14-Jun-2026
AgeneBio 01-Feb-2026
FAST BioMedical 17-Jul-2025
Gate Neurosciences 27-May-2025
Curvo Labs 20-May-2025
Lodos Theranostics 20-May-2025
Apexian Pharmaceuticals 01-Mar-2025
Lumavate 21-Nov-2024 Out of Business
MBX Biosciences 13-Sep-2024 IPO
You’re viewing 10 of 36 exits. Get the full list »

BioCrossroads Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

BioCrossroads FAQs

  • What is BioCrossroads?

    Founded in 2002, BioCrossroads is a venture capital firm based in Indianapolis, Indiana.

  • When was BioCrossroads founded?

    BioCrossroads was founded in 2002.

  • Where is BioCrossroads headquartered?

    BioCrossroads is headquartered in Indianapolis, IN.

  • What is BioCrossroads's total asset value?

    BioCrossroads has around in total assets under management.

  • How many investments has BioCrossroads made?

    BioCrossroads has made 77 investments.

  • What has BioCrossroads invested in?

    BioCrossroads has made numerous investments in companies like Antigenix Therapeutics, Gate Neurosciences, and Sabanto within the Drug Discovery, Pharmaceuticals and Biotechnology, and Machinery (B2B) industries.

  • What has BioCrossroads invested in recently?

    BioCrossroads's latest investment was on 18-Nov-2025 in Antigenix Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process